XML 50 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   19,729,923      
Beginning balance at Dec. 31, 2022 $ 354,556 $ 20 $ 444,255 $ 180,023 $ (269,742)
Beginning balance (in shares) at Dec. 31, 2022         5,573,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (3,962)     (3,962)  
Stock-based compensation 1,039   1,039    
Restricted stock issued (in shares)   24,903      
Restricted stock issued 0        
Restricted stock surrendered for employee tax payment (in shares)         6,000
Restricted stock surrendered for employee tax payment (620)       $ (620)
Shares issued for bonus settlement and director stipends (in shares)   1,006      
Shares issued for bonus settlement and director stipends 85   85    
Ending balance (in shares) at Mar. 31, 2023   19,755,832      
Ending balance at Mar. 31, 2023 351,098 $ 20 445,379 176,061 $ (270,362)
Ending balance (in shares) at Mar. 31, 2023         5,579,529
Beginning balance (in shares) at Dec. 31, 2022   19,729,923      
Beginning balance at Dec. 31, 2022 354,556 $ 20 444,255 180,023 $ (269,742)
Beginning balance (in shares) at Dec. 31, 2022         5,573,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (194,906)        
Ending balance (in shares) at Jun. 30, 2023   19,767,368      
Ending balance at Jun. 30, 2023 161,441 $ 20 446,694 (14,883) $ (270,390)
Ending balance (in shares) at Jun. 30, 2023         5,574,793
Beginning balance (in shares) at Mar. 31, 2023   19,755,832      
Beginning balance at Mar. 31, 2023 351,098 $ 20 445,379 176,061 $ (270,362)
Beginning balance (in shares) at Mar. 31, 2023         5,579,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (190,944)     (190,944)  
Stock-based compensation 1,021   1,021    
Exercise of employee stock options (in shares)   549      
Exercise of employee stock options 31   31    
Restricted stock issued (in shares)   9,116      
Restricted stock issued 0        
Restricted stock surrendered for employee tax payment (in shares)         3,138
Restricted stock surrendered for employee tax payment (221)       $ (221)
Shares issued for bonus settlement and director stipends (in shares)   1,871      
Shares issued for bonus settlement and director stipends 85   85    
Shares issued for ESPP (in shares)         (7,874)
Shares issued for ESPP 371   178   $ 193
Ending balance (in shares) at Jun. 30, 2023   19,767,368      
Ending balance at Jun. 30, 2023 $ 161,441 $ 20 446,694 (14,883) $ (270,390)
Ending balance (in shares) at Jun. 30, 2023         5,574,793
Beginning balance (in shares) at Dec. 31, 2023 19,775,041 19,775,041      
Beginning balance at Dec. 31, 2023 $ 156,195 $ 20 450,945 (24,437) $ (270,333)
Beginning balance (in shares) at Dec. 31, 2023 5,571,004       5,571,004
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (22,300)     (22,300)  
Stock-based compensation 1,973   1,973    
Restricted stock issued (in shares)   22,577      
Restricted stock issued 0        
Restricted stock surrendered for employee tax payment (in shares)         1,607
Restricted stock surrendered for employee tax payment (64)       $ (64)
Shares issued for bonus settlement and director stipends (in shares)   1,559      
Shares issued for bonus settlement and director stipends 37   37    
Ending balance (in shares) at Mar. 31, 2024   19,799,177      
Ending balance at Mar. 31, 2024 $ 135,841 $ 20 452,955 (46,737) $ (270,397)
Ending balance (in shares) at Mar. 31, 2024         5,572,611
Beginning balance (in shares) at Dec. 31, 2023 19,775,041 19,775,041      
Beginning balance at Dec. 31, 2023 $ 156,195 $ 20 450,945 (24,437) $ (270,333)
Beginning balance (in shares) at Dec. 31, 2023 5,571,004       5,571,004
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (151,184)        
Ending balance (in shares) at Jun. 30, 2024 19,814,005 19,814,005      
Ending balance at Jun. 30, 2024 $ 9,515 $ 20 455,185 (175,621) $ (270,069)
Ending balance (in shares) at Jun. 30, 2024 5,558,519       5,558,519
Beginning balance (in shares) at Mar. 31, 2024   19,799,177      
Beginning balance at Mar. 31, 2024 $ 135,841 $ 20 452,955 (46,737) $ (270,397)
Beginning balance (in shares) at Mar. 31, 2024         5,572,611
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (128,884)     (128,884)  
Stock-based compensation 2,159   2,159    
Restricted stock issued (in shares)   13,947      
Restricted stock issued 0        
Restricted stock surrendered for employee tax payment (in shares)         3,706
Restricted stock surrendered for employee tax payment (92)       $ (92)
Shares issued for bonus settlement and director stipends (in shares)   881      
Shares issued for bonus settlement and director stipends 23   23    
Shares issued for ESPP (in shares)         (17,798)
Shares issued for ESPP $ 468   48   $ 420
Ending balance (in shares) at Jun. 30, 2024 19,814,005 19,814,005      
Ending balance at Jun. 30, 2024 $ 9,515 $ 20 $ 455,185 $ (175,621) $ (270,069)
Ending balance (in shares) at Jun. 30, 2024 5,558,519       5,558,519